At the Investor Day event, Mr. Walt, along with other members of the management team, will provide a briefing on how the Company’s MosaiQ™ system is poised to meet the significant unmet needs of the transfusion market.
This event is by invitation only and registration is required. Investment professionals interested in attending the event in-person can request an invitation and/or RSVP for the event by contacting
A live webcast of the prepared remarks will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.
Quotient is a commercial-stage diagnostics company committed to ensuring clinical excellence and increasing the efficiency in the lab through the provision of innovative testing methods for existing tests within established markets. With an initial focus on blood grouping and serological disease screening, Quotient is developing its proprietary MosaiQ™ technology platform to offer a breadth of tests that is unmatched by existing commercially available transfusion diagnostic instrument platforms. The Company’s operations are based in
The Quotient logo and MosaiQ™ are registered trademarks or trademarks of
Source: Quotient Limited